A cohort evaluation of WHO class II and IV TB patients treated at the National Institute of Respiratory Diseases (INER)

A. García Cruz, S. Felson, R. Olvera Castillo (Mexico City, Mexico; Cleveland, United States Of America)

Source: Annual Congress 2001 - Management of mycobacterial disease
Session: Management of mycobacterial disease
Session type: Thematic Poster Session
Number: 3156
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. García Cruz, S. Felson, R. Olvera Castillo (Mexico City, Mexico; Cleveland, United States Of America). A cohort evaluation of WHO class II and IV TB patients treated at the National Institute of Respiratory Diseases (INER). Eur Respir J 2001; 16: Suppl. 31, 3156

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Analysis of risk factors in children with asthma exacerbations treated at the National Institute of Respiratory Diseases ²Ismael Cosio Villegas² (INER)
Source: International Congress 2016 – Living with asthma around the globe
Year: 2016


Evaluation of the Integrated Tuberculosis Research Programme (PII TB) by SEPAR (Spanish Respiratory Society)
Source: International Congress 2019 – Tuberculosis: a public health approach
Year: 2019

Longitudinal data-driven definition of clinical asthma phenotypes in the pediatric arm of the All Age Asthma Cohort (ALLIANCE) of the German Center for Lung Research (DZL)
Source: Virtual Congress 2020 – Hot topics in paediatric asthma
Year: 2020




Oesophagical surgery in the National Institute of Respiratory Diseases, Mexico
Source: Eur Respir J 2001; 18: Suppl. 33, 133s
Year: 2001

Cardiac sarcoidosis is more frequent in males – Large cohort (n=1375) sarcoid patients analysis – 5 years experience in the National TB & Lung Diseases Research Institute in Warsaw, Poland
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013

Outcome of treatment of TB/HIV patients in a referral center in Iran National Research Institute of Tuberculosis and Lung Disease
Source: Eur Respir J 2005; 26: Suppl. 49, 454s
Year: 2005

Comorbidities in 1779 sarcoidosis patients – 4 years experience in National Tuberculosis and Lung Diseases Research Institute in Warsaw, Poland
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012

Implementation of FAST strategy in the National Center for Tuberculosis and Lung Diseases (NCTLD) in Georgia
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018




Pharmacological treatment of asthma in a cohort of adults during a 20-year period: results from the European Community Respiratory Health Survey I, II and III
Source: ERJ Open Res, 5 (1) 00073-2018; 10.1183/23120541.00073-2018
Year: 2019



Clinical picture analysis of idiopathic pulmonary fibrosis (IPF) and lung cancer (LC) concomitance in the population of patients hospitalized in Ist Clinic of Lung Diseases Institute for Tuberculosis and Lung Diseases in Warsaw, Poland in the years 1994-2009
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011


Longitudinal characteristics of the Severe Asthma Research Program (SARP) clinical clusters
Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes
Year: 2020




Paediatric Respiratory Research Award II
Source: Annual Congress 2009 - Paediatric Respiratory Research Awards (supported by Merck & Co., Inc.)
Year: 2009


The European Community Respiratory Health Survey II
Source: Eur Respir J 2003; 21: 556-560
Year: 2003


A national example: German Centre for Lung Research
Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
Year: 2014


Survival among never and ever smokers with lung cancer in the Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) study
Source: Annual Congress 2010 - Epidemiology of lung cancer
Year: 2010


2011 Paediatric Respiratory Research Awardee II: Not Just Another Reference Equation
Source: Annual Congress 2011 - ERS Paediatric Respiratory Research Awards in Europe Ceremony (supported by Merck) followed by Paediatric Grand Round - an interactive session
Year: 2011


Mortality rates of COPD Patients in UK Electronic Health Records (Clinical Practice Research Datalink)
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Year: 2018

Children hospitalized with pneumonia in Department of Pediatrics, University Hospital Center Split (2010 – 2011)
Source: International Congress 2014 – Respiratory infections in children
Year: 2014

Association of selected risk factors which affect Chronic Obstructive Pulmonary Disease (COPD)among patients in the National Hospital for Respiratory Diseases (NHRD), Sri Lanka
Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease
Year: 2020

Results of the ISAAC phase III (International Study for Asthma and Allergies in Childhood) in Nis Center, Serbia and Montenegro
Source: Eur Respir J 2004; 24: Suppl. 48, 389s
Year: 2004